COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1182: Articles 11811-11820  | Next

Global Burden of Covid-19 Restrictions: National, Regional and Global Estimates
Fink, G., Tediosi, F., Felder, S.
10.1101/2021.09.21.21263825 — Posted: 2021-09-28
Effectiveness of the mRNA BNT162b2 vaccine against SARS-CoV-2 severe infections in the Israeli over 60 population: a temporal analysis done by using the national surveillance data.
De Leo, S.
10.1101/2021.09.27.21264130 — Posted: 2021-09-28 Discussion: Onsite
Sub-Saharan African Countries' COVID-19 Research: An analysis of the External and Internal Contributions, Collaboration Patterns and Funding Sources
Asubiaro, T. V., Shaik, H.
10.1101/2021.09.27.21264044 — Posted: 2021-09-28
"The vaccination is positive; I don't think it's the panacea": A qualitative study on COVID-19 vaccine attitudes among ethnically diverse healthcare workers in the United Kingdom
Gogoi, M., Wobi, F., Qureshi, I., Al-Oraibi, A., Hassan, O., Nellums, L. B., Pareek, M.
10.1101/2021.09.27.21264005 — Posted: 2021-09-28
Viral replication in human macrophages enhances an inflammatory cascade and interferon driven chronic COVID-19 in humanized mice.
Sefik, E., Qu, R., Kaffe, E., Zhao, J., Junqueira, C., Mirza, H., Brewer, R., Han, A., Steach, H., Israelow, B., Chen, Y. G., Halene, S., Iwasaki, A., Meffre, E., Nussenzweig, M., Lieberman, J., Wilen, C. B., Kluger, Y., Flavell, R. A.
10.1101/2021.09.27.461948 — Posted: 2021-09-27
COVID-19 L·OVE repository is highly comprehensive and can be used as a single source for COVID-19 studies
Verdugo-Paiva, F., Vergara, C., Avila, C., Castro, J., Cid Cid, J., Contreras, V., Jara, I., Jimenez, V., Lee, M. H., Munoz, M., Rojas Gomez, A. M., Roson-Rodriguez, P., Serrano-Arevalo, K., Silva-Ruz, I., Vasquez-Laval, J., Zambrano-Achig, P., Zavadzki, G., Rada, G.
10.1101/2021.09.21.21263849 — Posted: 2021-09-27
Epidemiology, Clinico-Pathological Characteristics, and Comorbidities of SARS-CoV-2 infected Pakistani Patients
Omer, S., Sarwar, M. B., Roman, M., Usman, M., Khan, M. A., Afzal, N., Qaiser, T. A., Yasir, M., Shahzad, F., Tahir, R., Ayub, S., Akram, J., Jahan, S.
10.1101/2021.09.25.21264111 — Posted: 2021-09-27
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis
Baker, D., MacDougall, A., Kang, A. S., Schmierer, K., Giovannoni, G., Dobson, R.
10.1101/2021.09.26.21264023 — Posted: 2021-09-27
Non-invasive Vagus Nerve Stimulation for Respiratory Symptoms of COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)
Tornero, C., Pastor, E., Garzando, M. d. M., Orduna, J., Forner, M. J., Bocigas, I., Cedeno, D., Vallejo, R., Staats, P., Liebler, E.
10.1101/2021.09.24.21264045 — Posted: 2021-09-27 Discussion: Offsite
Multi-omics approach identifies novel age-, time- and treatment-related immunopathological signatures in MIS-C and pediatric COVID-19
Sacco, K., Castagnoli, R., Vakkilainen, S., Liu, C., Delmonte, O. M., Oguz, C., Kaplan, I. M., Alehashemi, S., Burbelo, P. D., Bhuyan, F., de Jesus, A. A., Dobbs, K., Rosen, L. B., Cheng, A., Shaw, E., Vakkilainen, M. S., Pala, F., Lack, J., Zhang, Y., Fink, D., Oikonomou, V., Snow, A. L., Dalgard, C. L., Chen, J., Sellers, B. A., Montealegre Sanchez, G. A., Barron, K., Rey, E., Vial, M. C., Poli, M. C., Licari, A., Montagna, D., Marseglia, G. L., Licciardi, F., Ramenghi, U., Discepolo, V., Lo Vecchio, A., Guarino, A., Eisenstein, E. M., Imberti, L., Sottini, A., Biondi, A., Mato, S., Gerstbacher, D., Truong, M., Stack, M. A., Magliocco, M., Bosticardo, M., Kawai, T., Danielson, J. J., Hulett, T., Askenazi, M., NIAID Immune Response to COVID Group, , Chile MIS-C Group, , Pavia Pediatric COVID-19 Group, , Cohen, J. I., Su, H. C., Kuhns, D. B., Lionakis, M. S., Snyder, T. M., Holland, S. M., Goldbach-Mansky, R., Tsang, J. S., Notarangelo, L. D.
10.1101/2021.09.24.21263853 — Posted: 2021-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).